BOUNDLESS BIO, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
BOUNDLESS BIO, INC. (BOLD) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -2.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-09
- BOUNDLESS BIO, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -2.10%.
- BOUNDLESS BIO, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -6.70%, a 195.71% decline from fiscal 2023.
- BOUNDLESS BIO, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 7.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -2.10% 10-K · filed 2026-03-09 | |
| 2024-12-31 | -6.70% 10-K · filed 2026-03-09 | 6.70% 10-K · filed 2025-03-27 |
| 2023-12-31 | 7.00% 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |